artenimol has been researched along with pyrroles in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amalvict, R; Baret, E; Briolant, S; Pradines, B; Rogier, C; Savini, H; Souraud, JB | 1 |
| Amalvict, R; Baret, E; Briolant, S; Charras, S; Dormoi, J; Feraud, M; Huyghues des Etages, E; Pascual, A; Pradines, B | 1 |
| Briolant, S; Desgrouas, C; Dormoi, J; Pascual, A; Pradines, B; Travaillé, C | 1 |
3 other study(ies) available for artenimol and pyrroles
| Article | Year |
|---|---|
Atorvastatin as a potential antimalarial drug: in vitro synergy in combinational therapy with dihydroartemisinin.
Topics: Animals; Antimalarials; Artemisinins; Atorvastatin; Drug Combinations; Drug Synergism; Heptanoic Acids; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrroles | 2010 |
Proveblue (methylene blue) as an antimalarial agent: in vitro synergy with dihydroartemisinin and atorvastatin.
Topics: Antimalarials; Artemisinins; Atorvastatin; Drug Interactions; Heptanoic Acids; Inhibitory Concentration 50; Methylene Blue; Plasmodium falciparum; Pyrroles | 2012 |
Improvement of the efficacy of dihydroartemisinin with atorvastatin in an experimental cerebral malaria murine model.
Topics: Animals; Anti-Inflammatory Agents; Antimalarials; Artemisinins; Atorvastatin; Biomarkers; Disease Models, Animal; Drug Therapy, Combination; Female; Heptanoic Acids; Inflammation; Malaria, Cerebral; Mice; Mice, Inbred C57BL; Pyrroles; Survival Analysis; Treatment Outcome | 2013 |